ArticleCancers2025

Use of a Pathomics Signature to Predict the Prognosis of Hepatocellular Carcinoma with Cirrhosis: A Multicentre Retrospective Study.

Ting Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.